Clinical trial NCT05673642: Effect of Myofascial Release on Function and Mobility in Patients With TMD and Low Back Pain: A Randomized Trial
Official title: Effect of Myofascial Release Therapy Applied to Selective Muscles on Mobility and Function in Patients With Temporomandibular Dysfunction and Coexisting Low Back Pain: A Randomized Controlled Trial
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Temporomandibular Joint Disorder
Low Back Pain
Myofascial Release
Keywords: TMJ Disorder, Myofascial Release, Low back pain
Lead sponsor: Istanbul Medipol University Hospital
Sponsor class: OTHER
First posted: 2023-01-06
Enrollment: 45
Sex: ALL
Minimum age (years): 18
Maximum age (years): 50
Standard ages: ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: PARALLEL
Intervention model description: A parallel-group randomized controlled trial with three distinct arms.
Primary purpose: TREATMENT

Brief summary: We aim to compare the effectiveness of MFR and exercise therapy on mobility and function by investigating the effectiveness of the Myofascial Release Technique (MFR), which we will apply to the muscles we choose related to the facial system connection in participants with temporomandibular dysfunction (TMD) and low back pain.

Detailed description: We aim to compare the effectiveness of MFR and exercise therapy on mobility and function by investigating the effectiveness of the Myofascial Release Technique (MFR), which we will apply to the muscles we choose related to the facial system connection in participants with temporomandibular dysfunction (TMD) and low back pain.

Method and Material Working group (Group A): Myofascial release technique will be applied. A total of 10 sessions will be applied for 4 weeks, 3 times a week for the first 2 weeks, and 2 times a week for the next 2 weeks.

Exercise group (Group B): The stretching exercises that we planned to give to the exercise group were planned for the muscles to which we will apply myofascial technique.

• Control group (Group C): No application will be made to the control group. Evaluations will be made at the beginning of the study and at the end of 4 weeks. The evaluation parameters to be used are as follows; Oswestry Low Back Disability Survey, Algometer and Myotonometry.

Inclusion Criteria: Participants aged 18-50 years diagnosed with TMD,Persons with a score of 20% or more on the Oswestry waist index, and People with low back pain for more than 3 months,Persons with mechanical low back pain and lumbar disc herniation without neurological deficits will be included in the study.Persons with acute or chronic temporomandibular dysfunction will be included. Exclusion Criteria; Neurological problems,Presence of extruded and sequestered lumbar disc herniation,Cardiovascular symptoms and circulation problems,Infection,Fibromyalgia, Acute arthritis conditions,Those with spinal abnormalities,Fracture history, presence of dislocation / subluxation will be excluded

Eligibility criteria: Inclusion Criteria:

* Participants aged 18-50 years diagnosed with TMD
* Persons with a score of 20% or more on the Oswestry waist index, and
* People with low back pain for more than 3 months
* Persons with mechanical low back pain and lumbar disc herniation without neurological deficits will be included in the study.
* Persons with acute or chronic temporomandibular dysfunction will be included

Exclusion Criteria:

* Neurological problems,
* Presence of extruded and sequestered lumbar disc herniation
* Cardiovascular symptoms and circulation problems,
* Infection,
* Fibromyalgia, Acute arthritis conditions
* Those with spinal abnormalities,
* Fracture history, presence of dislocation / subluxation will be excluded

Primary outcomes:
measure: Algometer
timeFrame: 5 minute
measure: Myotonometry
timeFrame: 10 minute
Secondary outcomes:
measure: DC-TMD Evoluation
timeFrame: 10 minute
measure: Oswestry Low Back Disability Survey
timeFrame: 10 minute
Other outcomes:
Locations:
city: Istanbul
country: Turkey
facility: Istanbul Medipol University
Study officials:
affiliation: Istanbul Medipol University Turkey Istanbul
name: Ebru Senel topaloglu, 1
role: PRINCIPAL_INVESTIGATOR
References: